Andrey A. Poloznikov

This paper identifies HPPE as a bipartite Nrf2 activator that overcomes feedback regulation by inhibiting Bach1, showing potential for treating age-related neurodegeneration.

This study improves clinical outcome predictions by integrating pharmacokinetic simulations into in vitro testing for colorectal cancer, showing better classification of responders and non-responders than traditional methods.